- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 17 - Conclusion: Treatment Advancements and Final Remarks
During this segment, Patricia K. Coyle, MD, Leslie Fish, PharmD, and Gary M. Owens, MD, explain how research has expanded in the neurology field and discuss the therapeutic pipeline for multiple sclerosis (MS) with Dr Fred Lublin.
Dr Coyle discusses the potential of newly developing agents and explains that clinical trials are now testing the efficacy of these products, which is vital when considering data for future clinical guidelines.
However, Dr Owens suggests that expensive costs of treatment and the lack of clinical recommendations or guidelines can cause confusion to clinicians and challenge the future of MS.
Trends in Hospital Pricing for Vulnerable Emergency Department Users, 2021-2023
December 4th 2025Self-pay emergency department prices rose significantly from 2021 to 2023, especially at for-profit and system-affiliated hospitals, highlighting growing affordability challenges for uninsured and underinsured patients.
Read More
